Quigley Jill M.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Aug 5, 2024
- Accession no.
- 0001562180-24-006019
- Filed
- Aug 5, 2024
- Trade date
- Aug 1-2, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $113.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quigley Jill M.CIK 0001799780 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Common Stock | SSaleDisposed | −6,143 | $7.68 | −$47,178.24 | 23,857 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −8,857 | $7.50 | −$66,427.5 | 15,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.